01 10ASTRAZENECA
01 108946235
01 10Y
01 10Y
01 102032-08-08
Patent Expiration Date : 2032-08-08
US Patent Number : 8946235
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-3823
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-08
Patent Expiration Date : 2032-08-08
US Patent Number : 8946235
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-1777
Delist Requested :
Patent Use Description : TREATMENT OF PATIENTS ...
Patent Expiration Date : 2032-08-08
Patent Expiration Date : 2032-08-08
US Patent Number : 8946235
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-4010
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-08
Patent Expiration Date : 2032-08-08
US Patent Number : 8946235
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-2289
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-08
Patent Expiration Date : 2032-08-08
US Patent Number : 8946235
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-2289
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-08
Patent Expiration Date : 2032-08-08
US Patent Number : 8946235
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-3016
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-08
Patent Expiration Date : 2032-08-08
US Patent Number : 8946235
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-4010
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-08
Patent Expiration Date : 2032-08-08
US Patent Number : 8946235
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-3823
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-08
Patent Expiration Date : 2032-08-08
US Patent Number : 8946235
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-1777
Delist Requested :
Patent Use Description : TREATMENT OF PATIENTS ...
Patent Expiration Date : 2032-08-08
Patent Expiration Date : 2032-08-08
US Patent Number : 8946235
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 208065
Patent Use Code : U-3016
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2032-08-08
